AEPCX
Price
$54.29
Change
-$1.20 (-2.16%)
Updated
Dec 18 closing price
CIVAX
Price
$16.39
Change
-$0.37 (-2.21%)
Updated
Dec 18 closing price
Ad is loading...

AEPCX vs CIVAX

Header iconAEPCX vs CIVAX Comparison
Open Charts AEPCX vs CIVAXBanner chart's image
American Funds Europacific Growth C
Price$54.29
Change-$1.20 (-2.16%)
VolumeN/A
CapitalizationN/A
American Funds International Vntg 529-A
Price$16.39
Change-$0.37 (-2.21%)
VolumeN/A
CapitalizationN/A
AEPCX vs CIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. CIVAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a StrongSell and CIVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 131B vs. CIVAX (2.04B). CIVAX pays higher dividends than AEPCX: CIVAX (1.10) vs AEPCX (0.81). AEPCX was incepted earlier than CIVAX: AEPCX (24 years) vs CIVAX (5 years). AEPCX is a more actively managed with annual turnover of: 34.00 vs. CIVAX (15.00). AEPCX (250) and CIVAX (250) have matching initial minimum investment requirements. AEPCX annual gain was more profitable for investors over the last year : 7.63 vs. CIVAX (6.39). CIVAX return over 5 years is better than : 22.63 vs. AEPCX (4.81).
AEPCXCIVAXAEPCX / CIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years5 years-
Gain YTD5.4884.299128%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets131B2.04B6,425%
Annual Yield % from dividends0.811.1074%
Returns for 1 year7.636.39119%
Returns for 3 years-6.823.54-193%
Returns for 5 years4.8122.6321%
Returns for 10 years21.95N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAQX22.370.13
+0.58%
Morgan Stanley Inst Asia Opp I
MSEQX61.680.23
+0.37%
Morgan Stanley Inst Growth I
WOOQX19.14-0.19
-0.98%
JPMorgan SMID Cap Equity R4
EEMGX8.09-0.09
-1.10%
MFS Emerging Markets Equity Research R4
NINLX22.30-0.31
-1.37%
Neuberger Berman Intrinsic Value I